MDxHealth SA, announced the publication of positive data demonstrating the value of the SelectMDx liquid biopsy test for...
ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences and APCER Li...
Plasticell, a developer of stem cell technologies and therapies, has announced it is leading a consortium of pioneering ...
Singapore – Prothena Corporation, a clinical-stage biotechnology company focused on the discovery and development ...
Singapore – According to recent research, the insulin resistance and pancreatic beta-cell (β-cell) dysfunctio...
Singapore – Bio-Techne Corporation announced that it has reached agreement to acquire Exosome Diagnostics, Inc. fo...
Singapore – Orthofix International, a global medical device company focused on musculoskeletal products and therap...
Singapore - A drug to treat childhood epilepsy is expected this week to become the first medicine derived fro...
Singapore - Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on the develop...
In 2018, the Hamburg life science company is presenting its highly prestigious research prize for the 23rd time. The ind...
Swiss drug major Roche Group has appointed James Sabry as Global Head of Partnering, a role that combines the partnering...
A study from a Massachusetts General Hospital (MGH) research team reports that after three years of receiving two a...
Researchers funded by the National Institute on Aging (NIA), a part of the National Institutes of Health have made a dis...
Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, has embarked on a strategic collabora...
Singapore- PolarityTE announced that Paul Mann of Highbridge Capital Management is the new Chief Financial Officer of th...
The American Heart Association (AHA) and the American Diabetes Association (ADA) has announced the start of a new multi-...
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of new evidence that Cose...
Seema Kumar, Vice President of Innovation, Global Health and Science Policy Communication for Johnson & Johnson was ...
